Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Medpace Holdings Inc (NASDAQ: MEDP) was $544.77 for the day, down -5.50% from the previous closing price of $576.49. In other words, the price has decreased by -$5.50 from its previous closing price. On the day, 0.57 million shares were traded. MEDP stock price reached its highest trading level at $576.2882 during the session, while it also had its lowest trading level at $530.96.
Ratios:
Our analysis of MEDP’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 53.78 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 22.67. For the most recent quarter (mrq), Quick Ratio is recorded 0.57 and its Current Ratio is at 0.57. In the meantime, Its Debt-to-Equity ratio is 0.49 whereas as Long-Term Debt/Eq ratio is at 0.41.
Upgrades & Downgrades
In the most recent recommendation for this company, BMO Capital Markets on November 13, 2025, initiated with a Market Perform rating and assigned the stock a target price of $600.
On October 02, 2025, Barclays Downgraded its rating to Underweight which previously was Equal Weight but kept the price unchanged to $425.
Rothschild & Co Redburn Downgraded its Buy to Neutral on September 03, 2025, while the target price for the stock was maintained at $474.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 03 ’25 when Troendle August J. sold 668 shares for $590.69 per share. The transaction valued at 394,581 led to the insider holds 646,184 shares of the business.
Troendle August J. sold 23,178 shares of MEDP for $13,750,348 on Dec 01 ’25. The CEO now owns 652,550 shares after completing the transaction at $593.25 per share. On Dec 02 ’25, another insider, Troendle August J., who serves as the CEO of the company, sold 5,698 shares for $590.47 each. As a result, the insider received 3,364,498 and left with 646,852 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MEDP now has a Market Capitalization of 15345204224 and an Enterprise Value of 15203824640. As of this moment, Medpace’s Price-to-Earnings (P/E) ratio for their current fiscal year is 38.10, and their Forward P/E ratio for the next fiscal year is 32.77. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.74. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.51 while its Price-to-Book (P/B) ratio in mrq is 52.13. Its current Enterprise Value per Revenue stands at 6.447 whereas that against EBITDA is 28.39.
Stock Price History:
The Beta on a monthly basis for MEDP is 1.43, which has changed by 0.6446239 over the last 52 weeks, in comparison to a change of 0.12469888 over the same period for the S&P500. Over the past 52 weeks, MEDP has reached a high of $626.26, while it has fallen to a 52-week low of $250.05. The 50-Day Moving Average of the stock is -3.47%, while the 200-Day Moving Average is calculated to be 32.99%.
Shares Statistics:
MEDP traded an average of 310.49K shares per day over the past three months and 288490 shares per day over the past ten days. A total of 28.10M shares are outstanding, with a floating share count of 22.60M. Insiders hold about 19.79% of the company’s shares, while institutions hold 87.44% stake in the company. Shares short for MEDP as of 1763078400 were 1377401 with a Short Ratio of 4.44, compared to 1760486400 on 1676404. Therefore, it implies a Short% of Shares Outstanding of 1377401 and a Short% of Float of 6.1899999999999995.
Earnings Estimates
At present, 6.0 analysts are actively evaluating the performance of Medpace Holdings Inc (MEDP) in the stock market.The consensus estimate for the next quarter is $3.38, with high estimates of $3.86 and low estimates of $2.91.
Analysts are recommending an EPS of between $16.57 and $14.7 for the fiscal current year, implying an average EPS of $15.12. EPS for the following year is $16.49, with 8.0 analysts recommending between $17.88 and $14.94.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 10 analysts. It ranges from a high estimate of $708.49M to a low estimate of $678.5M. As of. The current estimate, Medpace Holdings Inc’s year-ago sales were $536.59MFor the next quarter, 10 analysts are estimating revenue of $679M. There is a high estimate of $712.36M for the next quarter, whereas the lowest estimate is $614.5M.
A total of 12 analysts have provided revenue estimates for MEDP’s current fiscal year. The highest revenue estimate was $2.53B, while the lowest revenue estimate was $2.5B, resulting in an average revenue estimate of $2.51B. In the same quarter a year ago, actual revenue was $2.11BBased on 12 analysts’ estimates, the company’s revenue will be $2.81B in the next fiscal year. The high estimate is $2.86B and the low estimate is $2.77B.
